Lymay Kouai
Medical · Huntingdon Valley, PANPI 1407214539
Payments from drug & device makers
Across 177 payments — averaging $21.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$704
- EMD Serono, Inc.$569
- UCB, Inc.$259
- Novartis$256
- Teva Pharmaceuticals USA, Inc.$211
- Amgen$211
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,796100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 41 | $704 |
| EMD Serono, Inc. | 23 | $569 |
| UCB, Inc. | 13 | $259 |
| Novartis | 11 | $256 |
| Teva Pharmaceuticals USA, Inc. | 11 | $211 |
| Amgen | 8 | $211 |
| Jazz Pharmaceuticals Inc. | 7 | $179 |
| Harmony Biosciences LLC | 4 | $151 |
| Biogen | 7 | $145 |
| Lilly USA, LLC | 5 | $117 |
| Pfizer | 5 | $107 |
| Amneal Pharmaceuticals LLC | 4 | $90 |
| AstraZeneca | 3 | $78 |
| Argenx US, Inc. | 2 | $65 |
| Bristol Myers Squibb | 4 | $65 |
| Acorda Therapeutics, Inc | 3 | $64 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $55 |
| SK Life Science, Inc. | 3 | $51 |
| Genentech USA, Inc. | 2 | $51 |
| MDD US Operations, LLC | 2 | $46 |
| TG Therapeutics, Inc. | 2 | $45 |
| Avadel CNS Pharmaceuticals, LLC | 2 | $40 |
| Eisai Inc. | 2 | $40 |
| Upsher-smith Laboratories LLC | 2 | $37 |
| Neurelis, Inc. | 2 | $35 |
| Biohaven Pharmaceuticals, Inc. | 2 | $34 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| Lundbeck LLC | 1 | $24 |
| Arbor Pharmaceuticals, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
How this compares
$3,796 in reported general payments places this provider in the 85th percentile of 2,594 medical providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XywavSodium,calcium,mag,pot Oxybate | 12 | $245,372 |
| UbrelvyUbrogepant | 19 | $18,641 |
| Aimovig AutoinjectorErenumab-Aooe | 11 | $12,083 |
| VimpatLacosamide | 12 | $11,937 |
| Ajovy AutoinjectorFremanezumab-Vfrm | 11 | $8,057 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 61 | $2,944 |
| Eletriptan HbrEletriptan Hydrobromide | 19 | $2,893 |
| Gabapentin | 74 | $2,061 |
| Levetiracetam | 95 | $1,901 |
| Lacosamide | 22 | $1,870 |
| Memantine Hcl | 13 | $951 |
| Topiramate | 46 | $687 |
| Donepezil Hcl | 50 | $600 |
| Lamotrigine | 15 | $407 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 16 | $407 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieUbrelvy | $704 | $18,64119 claims |
| UCB, Inc.Vimpat | $259 | $11,93712 claims |
| Upsher-smith Laboratories LLCTopiramate | $37 | $68746 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,594 medical providers in Pennsylvania.
Other medical in Huntingdon Valley
- Jacqueline KernaghanSpringfield$427K
- Drew SodaNew Hope$220K
- Angela KapalkoPhiladelphia$123K
- Linda PerryPhiladelphia$123K
- Cory DavidsonErie$119K
- Shelley SassamanTamaqua$90K
- Meghan HoffnerBethlehem$86K
- Thomas IacovoniDanville$72K
- Scott CoxWynnewood$66K
- Sarah SmithPhiladelphia$65K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.